Literature DB >> 17092285

The clinical significance of bone mineral density and testosterone levels in Korean men with non-mosaic Klinefelter's syndrome.

Ju Tae Seo1, Jae Seok Lee, Tae Hee Oh, Kwan Joong Joo.   

Abstract

OBJECTIVE: To measure bone mineral density (BMD) and testosterone levels in patients with non-mosaic Klinefelter's syndrome (KS), as a low BMD is common in hypogonadal men, but little is known about the relationship between BMD and serum testosterone levels in men with KS. PATIENTS, SUBJECTS AND METHODS: The study included 40 patients with KS and 20 healthy fertile men recruited as controls. Serum testosterone, follicle-stimulating hormone (FSH) and luteinizing hormone (LH) levels were measured by radioimmunoassay. The BMD was obtained at the lumbar spine (L2-4), femoral neck and Ward's triangle, by dual-energy X-ray absorptiometry.
RESULTS: The serum testosterone level was lower, while FSH and LH were higher, in patients with KS than in the control group (P < 0.001). Patients with KS had a significantly lower mean (sd) BMD at the lumbar spine, femoral neck and Ward's triangle, than the controls, at 0.88 (0.13) vs 1.09 (0.10) (P < 0.001), 0.78 (0.12) vs 0.87 (0.10) (P = 0.006) and 0.65 (0.12) vs 0.76 (0.11) g/cm(2) = 0.001), respectively. There was a linear correlation between all BMD values and serum testosterone levels in men with KS who had a low serum testosterone level.
CONCLUSIONS: There was a relationship between a lower BMD and testosterone levels in patients with KS. These findings suggest that low testosterone levels cause inadequate bone development and a low BMD in men with KS; therefore, testosterone replacement might be necessary to prevent bone mineral deficiency and future risk of fractures in men with KS who also have low serum testosterone levels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17092285     DOI: 10.1111/j.1464-410X.2006.06584.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  12 in total

Review 1.  Consensus statement on diagnosis and clinical management of Klinefelter syndrome.

Authors:  A F Radicioni; A Ferlin; G Balercia; D Pasquali; L Vignozzi; M Maggi; C Foresta; A Lenzi
Journal:  J Endocrinol Invest       Date:  2010-12       Impact factor: 4.256

2.  Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome.

Authors:  A Ferlin; R Selice; A Di Mambro; M Ghezzi; A Di Nisio; N Caretta; C Foresta
Journal:  Osteoporos Int       Date:  2015-05-12       Impact factor: 4.507

Review 3.  Breast cancer risk among patients with Klinefelter syndrome.

Authors:  Louise A Brinton
Journal:  Acta Paediatr       Date:  2011-01-18       Impact factor: 2.299

4.  Klinefelter Bone Microarchitecture Evolution with Testosterone Replacement Therapy.

Authors:  A Piot; I Plotton; S Boutroy; J Bacchetta; S Ailloud; H Lejeune; R D Chapurlat; P Szulc; C B Confavreux
Journal:  Calcif Tissue Int       Date:  2022-02-13       Impact factor: 4.000

Review 5.  The cognitive phenotype in Klinefelter syndrome: a review of the literature including genetic and hormonal factors.

Authors:  Richard Boada; Jennifer Janusz; Christa Hutaff-Lee; Nicole Tartaglia
Journal:  Dev Disabil Res Rev       Date:  2009

6.  Prospective evaluation of risk factors for male breast cancer.

Authors:  Louise A Brinton; Douglas A Richesson; Gretchen L Gierach; James V Lacey; Yikyung Park; Albert R Hollenbeck; Arthur Schatzkin
Journal:  J Natl Cancer Inst       Date:  2008-10-07       Impact factor: 13.506

7.  Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.

Authors:  N Tahani; L Nieddu; G Prossomariti; M Spaziani; S Granato; F Carlomagno; A Anzuini; A Lenzi; A F Radicioni; E Romagnoli
Journal:  Endocrine       Date:  2018-04-25       Impact factor: 3.633

8.  Genetic and hormonal control of bone volume, architecture, and remodeling in XXY mice.

Authors:  Peter Y Liu; Robert Kalak; Yanhe Lue; Yue Jia; Krista Erkkila; Hong Zhou; Markus J Seibel; Christina Wang; Ronald S Swerdloff; Colin R Dunstan
Journal:  J Bone Miner Res       Date:  2010-10       Impact factor: 6.741

9.  Clinical Presentation of Klinefelter's Syndrome: Differences According to Age.

Authors:  Néstor Pacenza; Titania Pasqualini; Silvia Gottlieb; Pablo Knoblovits; Pablo R Costanzo; Jorge Stewart Usher; Rodolfo A Rey; María P Martínez; Sergio Aszpis
Journal:  Int J Endocrinol       Date:  2012-01-12       Impact factor: 3.257

10.  Effect of testosterone replacement therapy on bone mineral density in patients with Klinefelter syndrome.

Authors:  Dae Gi Jo; Hyo Serk Lee; Young Min Joo; Ju Tae Seo
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.